CoChat
Sign Up
Cited by 140

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury

Medina-Caliz, Inmaculada, Robles-Diaz, Mercedes, Garcia-Muñoz, Beatriz, Stephens, Camilla, Ortega-Alonso, Aida, Garcia-Cortes, Miren, González-Jimenez, Andres, Sanabria-Cabrera, Judith A., Moreno, Inmaculada, Fernandez, M. Carmen, Romero-Gomez, Manuel, Navarro, Jose M., Barriocanal, Ana Mª, Montane, Eva, Hallal, Hacibe, Blanco, Sonia, Soriano, German, Roman, Eva M., Gómez-Dominguez, Elena, Castiella, Agustin, Zapata, Eva M., Jimenez-Perez, Miguel, Moreno, Jose M., Aldea-Perona, Ana, Hernández-Guerra, Manuel, Prieto, Martin, Zoubek, Miguel E., Kaplowitz, Neil, Lucena, M. Isabel, Andrade, Raul J.·2016·Journal of Hepatology
DOI 10.1016/j.jhep.2016.05.003PMC PMC7458366
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2016.05.003

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. Lucena, 2009, Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex, Hepatology, 49, 2001, 10.1002/hep.22895 · DOI · Paper page
  2. Kleiner, 2014, Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations, Hepatology, 59, 661, 10.1002/hep.26709 · DOI
  3. Björnsson, 2005, Outcome and prognostic markers in severe drug-induced liver disease, Hepatology, 42, 481, 10.1002/hep.20800 · DOI · Paper page
  4. Andrade, 2005, Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period, Gastroenterology, 129, 512, 10.1016/j.gastro.2005.05.006 · DOI
  5. Robles-Diaz, 2014, Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury, Gastroenterology, 147, 109, 10.1053/j.gastro.2014.03.050 · DOI · Paper page
  6. Chalasani, 2008, Causes, clinical features and outcomes from a prospective study of drug-induced liver injury in the United States, Gastroenterology, 135, 1924, 10.1053/j.gastro.2008.09.011 · DOI
  7. Fontana, 2014, Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset, Gastroenterology, 147, 96, 10.1053/j.gastro.2014.03.045 · DOI
  8. Seeff, 1981, Drug-induced chronic liver disease, with emphasis on chronic active hepatitis, Semin Liver Dis, 1, 104, 10.1055/s-2008-1040723 · DOI
  9. Aithal, 1999, The natural history of histologically proved drug induced liver disease, Gut, 44, 731, 10.1136/gut.44.5.731 · DOI
  10. Björnsson, 2009, The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice, J Hepatol, 50, 511, 10.1016/j.jhep.2008.10.021 · DOI · Paper page
  11. Benichou, 1990, Criteria of drug-induced liver disorders. Report of an International Consensus Meeting, J Hepatol, 11, 272, 10.1016/0168-8278(90)90124-A · DOI · Paper page
  12. Andrade, 2006, Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry, Hepatology, 44, 1581, 10.1002/hep.21424 · DOI · Paper page
  13. Fontana, 2009, Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct, Drug Saf, 32, 55, 10.2165/00002018-200932010-00005 · DOI · Paper page
  14. Aithal, 2011, Case definition and phenotype standardization in drug-induced liver injury, Clin Pharmacol Ther, 89, 806, 10.1038/clpt.2011.58 · DOI
  15. Fontana, 2015, Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury, Am J Gastroenterol, 110, 1450, 10.1038/ajg.2015.283 · DOI
  16. 2001, JAMA, 285, 2486, 10.1001/jama.285.19.2486 · DOI · Paper page
  17. Danan, 1993, Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  18. Björnsson, 2007, Long-term follow-up of patients with mild to moderate drug-induced liver injury, Aliment Pharmacol Ther, 26, 79, 10.1111/j.1365-2036.2007.03355.x · DOI
  19. Williams, 2012, Role of innate and adaptive immunity during drug-induced liver injury, Toxicol Res, 1, 161, 10.1039/c2tx20032e · DOI
  20. Lucena, 2011, Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis, J Hepatol, 55, 820, 10.1016/j.jhep.2010.12.041 · DOI · Paper page
  21. Andrade, 1999, Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist, J Hepatol, 31, 641, 10.1016/S0168-8278(99)80343-2 · DOI
  22. Pineda, 1999, Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine, J Hepatol, 31, 777, 10.1016/S0168-8278(99)80362-6 · DOI
  23. Andrade, 2000, Chronic liver injury related to use of bentazepam: an unusual instance of benzodiazepine hepatotoxicity, Dig Dis Sci, 45, 1400, 10.1023/A:1005520523502 · DOI
  24. Perdices, 2014, Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry, Rev Esp Enferm Dig, 106, 246
  25. Luparini, 2000, Possibly ranitidine-induced autoimmune hepatitis, Ann Ital Med Int, 15, 214
  26. Black, 1975, Isoniazid-associated hepatitis in 114 patients, Gastroenterology, 69, 289, 10.1016/S0016-5085(19)32568-5 · DOI
  27. Sharp, 1980, Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin, Ann Intern Med, 92, 14, 10.7326/0003-4819-92-1-14 · DOI
  28. Amit, 2002, Nitrofurantoin-induced chronic active hepatitis, Isr Med Assoc J, 4, 184
  29. Stricker, 1988, Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases, Hepatology, 8, 599, 10.1002/hep.1840080327 · DOI
  30. Olsson, 1992, Liver damage from flucloxacillin, cloxacillin and dicloxacillin, J Hepatol, 15, 154, 10.1016/0168-8278(92)90029-O · DOI
  31. Oikawa, 2005, Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report, World J Gastroenterol, 11, 5394, 10.3748/wjg.v11.i34.5394 · DOI
  32. Whiting-O’Keefe, 1991, Methotrexate and histologic hepatic abnormalities: a meta-analysis, Am J Med, 90, 711, 10.1016/S0002-9343(05)80060-9 · DOI
  33. Moradpour, 1994, Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis, Hepatology, 20, 1437, 10.1002/hep.1840200610 · DOI
  34. Yeung, 2003, Ramipril-associated hepatotoxicity, Arch Pathol Lab Med, 127, 1493, 10.5858/2003-127-1493-RH · DOI
  35. Mazeika, 1989, Chronic active hepatitis associated with diclofenac sodium therapy, Br J Clin Pract, 43, 125, 10.1111/j.1742-1241.1989.tb08690.x · DOI
  36. Clarke, 2006, Atorvastatin associated liver disease, Dig Liver Dis, 38, 772, 10.1016/j.dld.2006.04.013 · DOI
  37. Russo, 2014, Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network, Hepatology, 60, 679, 10.1002/hep.27157 · DOI
  38. Yao, 1997, Trimethoprim sulfamethoxazole-induced vanishing bile duct syndrome, Am J Gastroenterol, 92, 167
  39. Kowdley, 1992, Prolonged cholestasis due to trimethoprim sulfamethoxazole, Gastroenterology, 102, 2148, 10.1016/0016-5085(92)90346-Z · DOI
  40. Chalasani, 2015, Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study, Gastroenterology, 148, 10.1053/j.gastro.2015.03.006 · DOI · Paper page
  41. Chatrenet, 1993, Chronic active cirrhogenic hepatitis induced by fenofibrate, Gastroenterol Clin Biol, 17, 612
  42. Ghabril, 2014, Drug-induced nodular regenerative hyperplasia, Semin Liver Dis, 34, 240, 10.1055/s-0034-1375963 · DOI · Paper page
  43. Anania, 2002, Terbinafine hepatotoxicity resulting in chronic biliaryductopenia and portal fibrosis, Am J Med, 112, 741, 10.1016/S0002-9343(02)01109-9 · DOI
  44. Gendre, 2008, Terbinafine induced hepatitis with persistent cholestasis, Rev Med Suisse, 4, 736

Cited by

Sorted by citations

Metadata

Authors
Medina-Caliz, I., Robles-Diaz, M., Garcia-Muñoz, B., Stephens, C., Ortega-Alonso, A., Garcia-Cortes, M., González-Jimenez, A., Sanabria-Cabrera, J. A., Moreno, I., Fernandez, M. C., Romero-Gomez, M., Navarro, J. M., Barriocanal, A. M., Montane, E., Hallal, H., Blanco, S., Soriano, G., Roman, E. M., Gómez-Dominguez, E., Castiella, A., Zapata, E. M., Jimenez-Perez, M., Moreno, J. M., Aldea-Perona, A., Hernández-Guerra, M., Prieto, M., Zoubek, M. E., Kaplowitz, N., Lucena, M. I., & Andrade, R. J.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2016-09
Volume
65
Issue
3
Pages
532-542
ISSN
0168-8278
DOI
10.1016/j.jhep.2016.05.003
PMC
PMC7458366
Cited by
140
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review